Markers of gluten sensitivity in acute mania: A longitudinal study

Psychiatry Research

Volumn 196, Issue 1, 2012, Pages 68-71

  Dickerson, Faith ^a   Stallings, Cassie ^a   Origoni, Andrea ^a   Vaughan, Crystal ^a   Khushalani, Sunil ^a   Yolken, Robert ^b  

^a Stanley Research Program at Sheppard Pratt   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Gliadin antibody; Maria

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DEAMIDATED GLIADIN; GLIADIN; GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN G; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; IMMUNOREACTIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PRIORITY JOURNAL; REGRESSION ANALYSIS; SAMPLE SIZE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CELIAC DISEASE; FEMALE; GLIADIN; GLUTENS; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TRANSGLUTAMINASES;

EID: 84860625865     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.11.007     Document Type: Article

References (23)

1. Alaedini A., Green P.H. Narrative review: celiac disease: understanding a complex autoimmune disorder. Annals of Internal Medicine 2005, 142:289-298.
2. Alaedini A., Okamoto H., Briani C., Wollenberg K., Shill H.A., Bushara K.O., Sander H.W., Green P.H., Hallett M., Latov N. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. Journal of Immunology 2007, 178:6590-6595.
3. Briani C., Samaroo D., Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmunity Reviews 2008, 7:644-650.
4. Cascella N.G., Kryszak D., Bhatti B., Gregory P., Kelly D.L., McEvoy J.P., Fasano A., Eaton W.W. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population, 2011. Schizophrenia Bulletin 2011, 37:94-100.
5. Dickerson F.B., Stallings C., Origoni A., Boronow J., Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Progress in Neuropsychopharmacology & Biological Psychiatry 2007, 31:952-955.
6. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disorders 2011, 13:52-58.
7. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., Yang S., Krivogorsky B., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biological Psychiatry 2010, 68:101-104.
8. Dohan F.C., Martin L., Grasberger J.C., Boehme D., Cottrell J.C. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biological Psychiatry 1972, 5:127-137.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. (SCID-I/P) 1998, Biometrics Research, New York State Psychiatric Institute, New York, NY.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Non-patient Edition. (SCID-I/NP) 1998, Biometrics Research, New York State Psychiatric Institute, New York, NY.
11. Goldstein B.I., Kemp D.E., Soczynska J.K., McIntyre R.S. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. The Journal of Clinical Psychiatry 2009, 70:1078-1090.
12. Hamilton M. Development of a rating scale for primary depressive illness. The British Journal of Social and Clinical Psychology 1967, 6:278-296.
13. Huebner F.R., Lieberman K.W., Rubino R.P., Wall J.S. Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides 1984, 5:1139-1147.
14. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
15. Liu H.C., Yang Y.Y., Chou Y.M., Chen K.P., Shen W.W., Leu S.J. Immunologic variables in acute mania of bipolar disorder. Neuroimmunology 2004, 150:116-122.
16. O'Brien S.M., Scully P., Scott L.V., Dinan T.G. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. Journal of Affective Disorders 2006, 90:263-267.
17. Ortiz-Domínguez A., Hernández M.E., Berlanga C., Gutiérrez-Mora D., Moreno J., Heinze G., Pavón L. Bipolar Disorders 2007, 9:596-602.
18. Randolph C., Tierney M.C., Mohr E., Chase T.N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology 1998, 20:310-319.
19. Reichelt K.L., Landmark J. Specific IgA antibody increases in schizophrenia. Biological Psychiatry 1995, 37:410-413.
20. Sapone A., Lammers K.M., Mazzarella G., Mikhailenko I., Cartenì M., Casolaro V., Fasano A. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy and Immunology 2010, 152:75-80.
21. Wadee A.A., Kuschke R.H., Wood L.A., Berk M., Ichim L., Maes M. Serological observations in patients suffering from acute manic episodes. Human Psychopharmacology 2002, 17:175-179.
22. Wieser H. Chemistry of gluten proteins. Food Microbiology 2007, 24:115-119.
23. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry 1978, 133:429-435.